Finn
PLXS Electronic manufacturing services · EMS · Regulated markets · Defense · Thesis updated August 5, 2026

Cash fears vanish as new data center demand arrives

01 Running thesis

Cash returns as new markets open

Plexus answered its biggest question in Q3 fiscal 2026. The previous worry about poor cash conversion was resolved when the company delivered a 62-day cash cycle, its best result in over five years. At the same time, revenue hit a record $1.305 billion, up 28% year over year, and operating margins reached 6.3%.

The narrative has now shifted from a simple recovery to secular growth. This change is driven by the Industrial segment, where management highlighted a new $500 million funnel tied to data center power and thermal management. Both the Industrial and Aerospace/Defense sectors are expected to grow by more than 20% in fiscal 2026.

The main open question is whether the Healthcare/Life Sciences sector will drag on growth in fiscal 2027. Customers are expected to enter a digestion period after a strong year of new product launches. The bull case assumes the other segments will completely offset this temporary slowdown.

Finn's view acknowledges the rapid improvement. The stock has catalysts ahead if Plexus can convert its data center funnel into active revenue and generate more than $100 million in free cash flow next year.

Jul 2026Q3 fiscal 2026 results dismantled previous cash flow concerns. Plexus achieved a 62-day cash cycle, record revenue of $1.305 billion, and highlighted a new $500 million data center funnel.
May 2026Q2 fiscal 2026 showed a broad recovery. Industrial moved from a 3.7% Q1 decline to 20.6% growth, while all three market sectors grew at double-digit rates and operating margin reached 5.3%.
Feb 2026Q1 fiscal 2026 reduced the fear of a slow recovery, with Healthcare/Life Sciences up 24.6% and Aerospace/Defense up 11.5%. Industrial still fell 3.7%, and the company guided to a fiscal 2026 effective tax rate of about 16.0% to 18.0%.
Nov 2025Fiscal 2025 net sales grew only 1.8%, which cooled the recovery story. The 10-K also added a clearer global minimum tax risk tied to tax holidays and future effective tax rates.
Aug 2025Q3 fiscal 2025 improved the demand picture. Industrial returned to 2.9% growth, Healthcare/Life Sciences grew 10.6%, and Aerospace/Defense grew 3.2%.
May 2025Q2 fiscal 2025 showed recovery in two of three markets, with Healthcare/Life Sciences up 8.5% and Aerospace/Defense up 1.3%. Industrial fell 5.1%, making that segment the main new concern.
Jan 2025Q1 fiscal 2025 showed mixed demand but better profitability. Industrial grew 1.8%, Healthcare/Life Sciences fell 1.8%, Aerospace/Defense fell 4.4%, and gross margin improved to 10.3%.
Nov 2024The initial view framed Plexus as a specialized electronics manufacturing partner. Fiscal 2024 revenue fell 5.9%, as Aerospace/Defense strength was offset by weakness in larger Healthcare/Life Sciences and Industrial markets.
02 Business model

Complex products for picky customers

Plexus does not sell its own branded products. It helps other companies design, source parts for, launch, build, and support complex electronics. Its customers are in markets where mistakes can be costly, such as medical devices, defense systems, industrial automation, and semiconductor equipment.

The company works in two main ways. In a turnkey job, Plexus buys the parts and delivers the finished product. In a consignment job, the customer supplies some or all of the parts. Turnkey work can create more revenue, but it also ties up cash in inventory.

The strategy is not to chase the highest volume consumer gadgets. Plexus aims for harder, lower-volume products with strict rules and long customer relationships. Its financial goal is a 15% return on invested capital, meaning profit compared with the money tied up in plants, inventory, and other assets.

That model breaks when demand shifts quickly or parts are hard to get. It also breaks if customers do not give long-term purchase commitments, because Plexus may still need to hire people and buy materials before orders fully arrive.

03 Product portfolio

Services, not house brands

Option

Design & Development

Plexus helps customers turn ideas into manufacturable products. This can pull the company into programs earlier and make later production work more likely.

Steady

Supply Chain Solutions

The company sources parts and manages suppliers for complex products. This is useful for customers, but it can consume cash when inventory rises ahead of sales.

Growth engine

New Product Introduction

Plexus helps move new products from prototype to production. Recent revenue growth includes production ramps for new customers and new products.

Cash cow

Manufacturing

Manufacturing is the core work. Scale and good factory use help margins when demand improves.

Steady

Sustaining Services

Plexus supports products after launch, helping keep them in the market longer. This can be steadier than one-time launch work.

04 Business segments

Three main end markets

Industrial41%growing fast
Healthcare/Life Sciences41%modest
Aerospace/Defense18%growing fast

Mix is based on Q2 fiscal 2026 net sales by market sector. Plexus manages its market strategy around Industrial, Healthcare/Life Sciences, and Aerospace/Defense.

05 Risk factors

What could still go wrong

Healthcare segment digestion

Medium impact · High odds

The Healthcare/Life Sciences segment faces a digestion period in fiscal 2027 following a strong year of new product launches. If this slowdown is deeper than expected, it could drag on consolidated revenue growth.

We watchYear-over-year revenue growth in the Healthcare/Life Sciences segment during fiscal 2027.

Supply chain tight spots return

Medium impact · Medium odds

Plexus recently solved its inventory buildup and improved its cash cycle. However, if new component shortages emerge, the supply chain team might need to build excess inventory again to secure parts, which would hurt cash flow.

We watchOperating cash flow, inventory days, and cash cycle metrics in future quarters.

Customer concentration cuts both ways

High impact · Medium odds

The top 10 customers were 49.1% of fiscal 2025 net sales. Plexus also says customers generally do not give long-term purchase commitments. A lost program, delayed order, or customer inventory correction can hit factories and margins quickly.

We watchTop customer concentration, major program wins or losses, and signs of customer order delays.

Global minimum tax lowers earnings power

Medium impact · High odds

Plexus has benefited from tax holidays, including in Malaysia. Management warned that global minimum tax rules are expected to materially and unfavorably affect those benefits and the effective tax rate.

We watchEffective tax rate guidance, updates on Malaysian tax holidays, and any change in global minimum tax rules.

Regulated products raise the cost of mistakes

Medium impact · Low odds

Plexus serves customers where product quality and rules matter a lot. A manufacturing defect, audit issue, or compliance failure could damage customer trust and delay production.

We watchRegulatory disclosures, quality issues, recalls, customer audits, and delays tied to compliance.
06 Quick answers

In one breath

What does Plexus Corp. do?

Plexus helps other companies design, source, launch, manufacture, and support complex electronics. It focuses on regulated and high-complexity markets such as Industrial, Healthcare/Life Sciences, and Aerospace/Defense.

Does Plexus sell its own products?

No. Plexus is mainly a product lifecycle and manufacturing partner. Its value comes from helping customers build difficult products, not from selling a Plexus-branded device.

Why is cash flow a focus for PLXS?

Because the company often builds inventory to support program ramps. In Q3 2026, Plexus improved its cash cycle to 62 days, proving it could manage inventory efficiently.

What are Plexus's main end markets?

In Q2 fiscal 2026, Industrial was 41.1% of sales, Healthcare/Life Sciences was 40.6%, and Aerospace/Defense was 18.2%. All three grew at double-digit rates that quarter.

Get started with Finn today